Search Immortality Topics:

Page 5«..4567..1020..»


Category Archives: Longevity

John Rivella is proof that tennis is the best game for longevity – Islander News.com

Two months before his 87th birthday, John Rivella walked off the clay courts at the Key Biscayne Tennis Association yet another doubles victory in his bag.

"I had a 17-year-old pro as my partner. I didn't have to do anything," he joked after the 6-0, 6-1 triumph.

If tennis leads to longevity, as experts have said, Rivella might be a perfect example, bouncing back from a complete left knee replacement in 2015.

"It worked out," he said of his titanium knee."I don't know many players beyond 60 who don't have some kind of knee or shoulder surgery. For us, it's like a tattoo."

Tennis has been called the best single sport for longevity, according to at least two global studies published by the world-renowned Mayo Clinic.

Six years ago, Danish researchers, following a British study from the previous year, observed more than 8,000 participants for about 25 years to compare a variety of sports, and tennis again proved to be the clear winner, associated with a 9.7-year longer lifespan.

One explanation, researchers said, was that the sport mimics interval training, with high- and low-intensity bursts of training. Also, players felt less stress when in close proximity to friends with the goal of improving while having fun outdoors each time out.

By comparison, badminton was shown to add an average of 6.2 years to life expectancy, researchers said, followed by soccer (4.7 years), cycling (3.7 years), swimming (3.4 years) and jogging (3.2 years).

Rivella, a Key Biscayne resident who enjoyed spending time on vacations here from New York City even as far back as 1969, plays tennis "about 5 or 6 times a week" and has earned a 3.5 United States Tennis Association ranking for club players.

"My theory is if I walk on that court and I'm healthy, and I walk off and I'm still healthy, then it's a great day," he said, tongue-in-cheek.

But he isn't buying the direct correlation analysis of longevity to his favorite sport.

"I don't believe that ... too many factors are involved, like cancer, blood disease. It doesn't matter how much tennis you play," he said. "I've lost a lot of good friends in their '70's, and many have succumbed to cancer."

He does see many benefits in playing tennis, though, especially in South Florida.

"First of all, you have the fresh air," he said. "Here, we have 12 months, which is conducive to playing outdoors. Sometimes, it gets a little too hot. And you're getting exercise. I can't stand going to a gym and exercising. It's not competitive. But, with tennis, you're getting off the couch, going outdoors and doing something. If I were to put up golf next to tennis, I'd say tennis is far more beneficial and (less) time-consuming."

He credits his healthiness to his family's strong bloodline.

"My father lived to 102; my mother 98; my sister, Dolores Schifano, is 94 in New Jersey and is still kicking around. She doesn't do exercise ... we just inherited good genes."

Jon Garito, 73, plays tennis six times a week. He is a firm believer that the sport helps one age gracefully.

"Anyone over 70 who plays tennis can attest to the longevity of tennis players and those who play other racket sports as well," he said. "It's not just the physical exercise but the mental stimulation and the socialization of the sport."

When he's on the court, he really doesn't see age discrepancies.

"In some games, I'm the younger player. I've played with players who are in their upper 80's," Garito said, pointing specifically to Rivella.

"He has amazing energy combined with crafty play. What I and other players my age and older enjoy is socialization. Especially the trash-talking before, during and after the game," Garito said. "We all look forward to the post-game conversation, the ceviche and the beverages."

As the president of the Key Biscayne Tennis Association (like Garito was), Rivella works at the club more than four hours a day in addition to playing. A few weeks ago, he helped dig a 10-foot-long trench to locate a water leak.

"Good exercise," he said.

As a child, Rivella enjoyed boxing for some 12 years before landing a job with US Steel in Pittsburgh and getting transferred to New York City. He'd often visit Key Biscayne from his winter home in Ft. Lauderdale and even owned a clothing store on the posh Worth Avenue in Palm Beach.

He said he never jogged, and he's not a very good swimmer, so tennis became his passion on Key Biscayne.

"I just think, basically, just being totally active ... tennis, cutting bushes and raking," he said, noting he's come upon foxes and even a yellow python around the tennis "jungle" at the complex.

Garito, meanwhile, also enjoys staying active and the camaraderie that comes with the sport.

"Here in Key Biscayne, we have an added feature of diverse cultures, making socialization even more interesting," he said. "The Mayo Clinic study confirms what we experience in our golden years on the tennis courts every day!"

View post:
John Rivella is proof that tennis is the best game for longevity - Islander News.com

Posted in Longevity | Comments Off on John Rivella is proof that tennis is the best game for longevity – Islander News.com

The keys to longevity may start in the lab. How aging science is expanding : Shots – Health News – NPR

I used to flinch at the topic of aging. Is there anything we can do about the inevitable?

But recently I've been digging into a new wave of longevity research that is making it an exciting time to be an aging human which is all of us.

It turns out, we all age at varying rates. Super-agers may have great genes, but research shows our habits and routines everything from what we eat and how we move our bodies to who we spend our time with matter a lot, when it comes to aging well.

Now, the next frontier is to target the basic biology of aging and come up with new interventions to slow it down.

Many scientists are optimistic that we're on the cusp of breakthroughs. Not only to help us live longer, but more importantly to extend the number of years we live with good health.

This is the goal of researchers at the Human Longevity Lab at the Northwestern University Feinberg School of Medicine. They're recruiting study participants so they can test what kinds of interventions may slow the rate of aging. To that end, I decided to roll up my sleeve for science.

When I arrived, the first step was a quick blood draw. The Potocsnak Longevity Institute is housed on the light-filled 21st floor of Northwestern Memorial Hospital, overlooking Lake Michigan. It felt more like a spa than a doctor's office. I didn't anticipate the vast range of data and insights scientists could glean from a battery of tests.

Over a four-hour period, they performed more than two dozen assessments. At first it felt a bit like an annual physical. They checked my blood pressure, weight, glucose and cholesterol.

NPR's Allison Aubrey has her body composition measured inside a BodPod. Several other tests performed at the longevity lab led by Dr. Douglas Vaughan are used to estimate biological age. Jane Greenhalgh/NPR hide caption

NPR's Allison Aubrey has her body composition measured inside a BodPod. Several other tests performed at the longevity lab led by Dr. Douglas Vaughan are used to estimate biological age.

But then, the tests got a lot more interesting. Inside a small exam room, a medical assistant opened the hinge of a BodPod, a capsule that looks like a submersible. The machine assessed my body composition, determining the ratio of fatty mass to lean mass, which includes muscle. Strength is a key marker of healthy aging, helping us fend off frailty and falls.

Next, I was asked to sniff and identify a range of distinct smells from leather to chocolate to test olfactory function. The loss of smell can be an early sign of disease and cognitive decline. They scanned my retina and took digital images of the inside of my eyes, which can also help detect disease. And I took a memory and cognitive function test, called MOCA. Thankfully, all was healthy.

Then I went through a slew of cardiovascular health tests. They measured my endothelial function, which keeps blood flowing smoothly through the body. They looked at my heart rate variability and pulse-wave velocity, which is an indicator of stiffness of the arteries. I had electrodes placed onto my chest for an electrocardiogram.

Midway through I was feeling a bit nervous, and my mind raced to what ifs.

Of all the tests they performed, the most intriguing is the GrimAge test. This test predicts biological age. It's gauging whether your DNA age is younger, or older, than your actual age, known as chronological age. Conjure images of the Grim Reaper? Yep, that's the idea: The test can estimate how quickly, or slowly, you're aging.

To figure this out, researchers use a technique based on DNA methylation, which is a measure of modifications in our DNA. Basically, as we age, compounds called methyl groups attach to some of our DNA molecules, which can turn genes on or off. Researchers have shown that the higher the proportion of methylated DNA in certain locations, the more accelerated a person's biological age. Published research suggests this is a reliable way to predict life span and health span.

No one wants to find out they're aging faster than their peers, right? But here's the exciting part. Our biological age may be malleable. The hope is that we can slow down our rate of aging by making changes to lifestyle. Down the line, there may be anti-aging pills or other interventions.

Dr. Douglas Vaughan and Dr. John Wilkins of the Northwestern University Feinberg School of Medicine and the Potocsnak Longevity Institute. Allison Aubrey/NPR hide caption

Dr. Douglas Vaughan and Dr. John Wilkins of the Northwestern University Feinberg School of Medicine and the Potocsnak Longevity Institute.

For researchers, the GrimAge test isn't just a way to estimate DNA age. It's a tool to study whether interventions can alter it.

"That's the big ray of optimism that comes through all of this the possibility that we can slow down aging and extend the health span of people," says Dr. Douglas Vaughan, director of the Longevity Institute. Health span is the number of years we live with good health. "It can be changed very rapidly in experimental models and probably in people, too," he says.

For example, smoking has a very strong effect on methylation. "Tens of thousands of locations gain methylation when you smoke," explains researcher Steve Horvath, who developed the epigenetic clock used as part of the GrimAge test. People with obesity also exhibit higher methylation at certain locations. "Conversely, if you eat vegetables, if you are lean, if you exercise, that slows methylation age," he explains.

Now, of course, it's long been known that smoking and eating poorly are bad for you. But researchers can now test specific interventions to see if it's possible to move the needle.

Vaughan's deep interest in aging took off when he identified a distinct genetic variant in an Amish community in Indiana. People who have the variant are protected from diabetes and have healthier cardiovascular systems compared to people who don't. In the laboratory, when Vaughan engineered mice to have only a 50% level of a protein associated with this mutation, their life spans increased by nearly fourfold. "This was a eureka moment," he says.

He tells his current medical students that in their careers they will prescribe interventions to slow down biological aging in their patients.

"I don't know exactly what that's going to be. It might be a drug. It might be a lifestyle intervention, for all I know it might be gene editing," Vaughan says. "But there are going to be ways that we are going to slow down this process and give people a longer health span."

People who live in the upscale Chicago neighborhood where the Human Longevity Lab is located can expect to live a much longer, healthier life compared to people who live just a few miles away. Vaughan wants to help close this gap.

"I'm worried about the poor soul in south Chicago who has a life expectancy of 55, compared to 92 in the neighborhood where we're standing right now," he says. A stunning difference of more than 30 years. (You can check out life expectancy in your ZIP code here.)

A lot of factors play into this life expectancy gap including poverty, housing, stress and crime, which can all work against health span.

Vaughan and his collaborators are enrolling people from a wide range of ages, ethnic groups, neighborhoods and socioeconomic status to see what works to slow biological aging for everybody.

"There are lots of people who've been dealt a bad hand with regard to aging," Vaughan says. Their goal is to find affordable, evidence-based interventions that can benefit everyone, regardless of socioeconomic status.

For example, there's interest in studying stress, which Vaughan says could be "part of the reason for the discrepancy in the life expectancy in different neighborhoods of Chicago." To study this, he could measure people's biological age at baseline, have them try a stress-reduction program, and test again to see if their results changed.

Vaughan is also interested in studying people with chronic HIV, who tend to age at an accelerated rate. A charitable gift from a Chicago family with a shared interest helped launch the institute. Vaughan's team is considering a range of interventions to test whether they can slow down aging in this population.

"It might be weight training, it might be intermittent fasting, it might be dietary manipulations, it might be drugs that are available now that might have anti-aging effects," Vaughan explains, citing the diabetes drug metformin.

Longevity and health span research is attracting lots of funding and attention, from places like the Hevolution Foundation, which provides grants and early stage investments, and Altos Labs, a biotechnology company, founded by Dr. Rick Klausner, which is investigating ways to reprogram or rejuvenate cells.

Dozens of groups have signaled their intent to compete in the $101 million X-PRIZE global competition focused on treatments that support healthy longevity everything from new drugs or supplements, to devices, to repurposing old drugs for new uses.

"Teams have to come to the starting line and we're going to set up the frameworks by which they prove their therapeutic works," says XPRIZE's Jamie Justice, who is also a researcher at Wake Forest University School of Medicine.

Fortunately, my GrimAge score came back younger than my actual age, though I did get some surprises. I learned that my body composition isn't optimal. Turns out, I need to build more lean muscle mass, which is pretty common as we age especially for women.

With muscle mass, if you don't use it, you lose it. After the age of 30 to 35, muscle starts to slowly decline. And after age 65 or so, this loss accelerates. So it's never too soon to start building a reserve. My goal for this year is to build muscle through resistance training and an optimal diet. And also, to reduce stress.

My experience in the longevity study has motivated me to get started on a new project: How To Thrive As You Age. We'll have more stories on healthy aging interventions coming soon.

As part of this project, we hope you'll share your healthy aging tips with us. What habits or lifestyle hacks have you've adopted to thrive as you age? Please use this form to share your thoughts or email us at Thrive@npr.org.

Continued here:
The keys to longevity may start in the lab. How aging science is expanding : Shots - Health News - NPR

Posted in Longevity | Comments Off on The keys to longevity may start in the lab. How aging science is expanding : Shots – Health News – NPR

The Dogs That Live Longest, by a Nose – The New York Times

All dogs go to heaven. But a bulldog might find itself headed there years before a Border terrier, according to a new study of nearly 600,000 British dogs from more than 150 breeds.

Large breeds and breeds with flattened faces had shorter average life spans than smaller dogs and those with elongated snouts, the researchers found. Female dogs also lived slightly longer than male ones. The results were published in the journal Scientific Reports on Thursday.

There are exceptions to those broad trends, and the findings might not apply to dogs outside Britain, where breeding practices and gene pools may be different, the researchers noted.

More research will be needed to determine why some breeds have shorter life spans than others. Some breeds are genetically predisposed to serious health problems, but breed-related differences in behavior, lifestyle, diet, environment or other factors could also play a role in shortening some dogs lives, experts said.

Now that we have identified these populations that are at risk of early death, we can start looking into why that is, said Kirsten McMillan, an author of the new study and the data manager at Dogs Trust, a dog welfare charity in Britain that led the research. This provides an opportunity for us to improve the lives of our dogs.

We are having trouble retrieving the article content.

Please enable JavaScript in your browser settings.

Thank you for your patience while we verify access. If you are in Reader mode please exit andlog intoyour Times account, orsubscribefor all of The Times.

Thank you for your patience while we verify access.

Already a subscriber?Log in.

Want all of The Times?Subscribe.

Read the original:
The Dogs That Live Longest, by a Nose - The New York Times

Posted in Longevity | Comments Off on The Dogs That Live Longest, by a Nose – The New York Times

Secret agent protein could help understand longevity and cancer – Cosmos

The double life of a tiny protein might have big implications for research in longevity, cancer, neurodegenerative and inflammatory diseases.

A team of German and Australian scientists has found that the protein TFEB plays a big role in helping mitochondria the so-called powerhouse of the cell to function.

Transcription factor EB, or TFEB, was known to be a protein that helped with transcribing DNA in the nucleus of a cell. It also helped with autophagy: recycling and clearing out junk in the cell.

Its not only present in humans its also present in other species of animals, but not in very small animals like worms, says Dr Nirmal Robinson, a senior research fellow at the University of South Australias Centre for Cancer Biology, and senior author on a paper published in EMBO Reports.

More recently, researchers had started to understand that TFEB is also involved in regulating mitochondria.

Mitochondria convert energy into the highly transportable molecule ATP, as well as helping metabolise things and provoking inflammation when theres an external threat.

TFEB played a major role in longevity thats how we got interested in it, says Robinson.

But once theyd started investigating it, Robinson and his colleagues at the University of Cologne and the Max Planck Institute, both in Germany, found that TFEB was working in mysterious ways.

The striking thing that we found was even if it does not move into the nucleus, if you deplete the protein, then there was an increase in inflammation.

So that said that it should have some function other than just in the nucleus.

Through a series of different tests including testing the reaction of TFEB to invasive bacteria, assays to see which proteins TFEB sticks to, then electron microscopy the researchers uncovered a more detailed picture of what the protein was up to.

They found TFEB wasnt just sticking to the outside of the mitochondria it was moving right into the inner regions. And weirdly, even though theres DNA inside the mitochondria too, the protein wasnt working with DNA.

It binds to a protein called LONP1, which is a mitochondrial protease, says Robinson.

Together, TFEB and LONP1 work with a thing called the mitochondrial complex I, which helps regulate the energy moving through the mitochondria. Robinson says it applies a brake to mitochondrial function, stopping it from becoming too reactive and increasing inflammation.

Its very unconventional, and it has not been shown before, says Robinson.

There are many proteins which have been shown to do multiple things. But not many transcription factors like TFEB, which move into the nucleus, could also move in inside the mitochondria because the proteins which move into the mitochondria are very strictly regulated.

TFEBs mitochondrial multitasking has wide-ranging implications for disease research.

One of the things that we see is that when you dont have this protein moving into the into the mitochondria, some cancer cells tend to multiply very rapidly. That suggests that the mitochondria cannot be just revving itself uncontrollably. You need this [protein] to go and put a brake on it, says Robinson.

It could also play a role in aging-related diseases, and inflammation. Robinson and colleagues are hoping to run studies on mice and other animals, like fish, to see what happens if this protein is left in the nucleus, but doesnt make it across to the mitochondria.

What happens to an animal when that protein is not able to move into the mitochondria? Will they age normally? Will there be a problem in aging and in cancer models? What does it do in terms of disease pathologies? asks Robinson.

Such research would lead to developing new therapeutics, although on-the-shelf medicines are likely decades away.

Excerpt from:
Secret agent protein could help understand longevity and cancer - Cosmos

Posted in Longevity | Comments Off on Secret agent protein could help understand longevity and cancer – Cosmos

One Norse God Could Be Valheim’s Key to Longevity – GameRant

Highlights

Valheim, despite being in early access, has stuck it out in the survival scene for years with great success. For the title to maintain this longevity, Valheim may want to look to its mythological grounding for inspiration.

Players can already observe Valheim using its foundations in Norse mythology to keep the title relevant. Valheim's upcoming Ashlands update, for instance, will be adding new enemies in this veinsuch as the Fallen Valkyrie, representing a twisted version of the spirits that assist Odin and carry souls to Valhalla. While the decrepit, undead visages of these creatures are closer to harpies than valkyries, there is a precedent for valkyries having a brutal, unlawful side to them in some parts of Norse myth (particularly older sources).

Loki is a being from Norse myth with a level of notoriety that rivals Thor himself. He's become a pop culture staple as both antagonist and antihero, especially with the MCU's wildly popular portrayal of the charactergaining him his own spinoff show Loki on Disney+. He's also had his share of video game appearances, with the recent Asgard's Wrath 2 presenting Loki as a villain played by renowned voice actor Matthew Mercer. However, Loki's real mythological story is far more complex than as merely a god of mischief, something that lends well to giving Valheim more than a little creative energy for long into the future.

Loki's an exceptionally chaotic god, not only in his shifting roles throughout sources in Norse myth but through his unpredictable actions. He's among the Aesir, a subset of Norse gods that includes Thor and Odin (who have both already appeared in Valheim). He accompanies Thor on many adventures, such as in Thrymskvitha, where the pair scheme to get Thor's hammer back from a giant who stole it. However, Loki is also responsible for the death of the beloved Baldr by tricking the blind god Hodr into throwing a mistletoe spear at him. This eventually led to him being imprisoned by his fellow gods.

Loki's dual nature as both ally and enemy cements his trickster qualitiesperfect for shifting up Valheim's gameplay loop. Letting Loki into the tenth realm would be a great opportunity for not only a new NPC, but raid-like events that inject chaos into play. Illusions and shapechanging are staples of the god in popular media and in the Eddic texts, and they'd make for excellent ways to temporarily remix enemies and terrain.

Valheim's gods are mostly relegated to Easter eggs right now. The game is foregrounded by lore wherein the player is a champion of Odin, fighting the Allfather's nemeses. Despite this, Odin and Thor only make brief background cameos. Loki directly toying with the player could be a great way to introduce the Norse gods as a more present force. Whether his machinations manifest as helpful companionship or cruel pranks, he could very well be the impetus for more of the Norse pantheon to get involved.

In Jan De Vries' 1933 work The Problem of Loki, a great deal about the god's conflicting origins is collected. Among Loki's numerous attestations, he's been linked to the Ancient Greek titan Prometheusan enlightening rebel against tyrannical fellows, a presentation seen in Richard Wagner's opera cycle The Ring of the Nibelung. However, Christianization has also seen the trickster be linked to the devil, helped along by the theory that the term 'logi' (meaning 'fire') developed into 'Loki', with many scholars accepting the god's link to fire. These manifold facets allow for Valheim to take artistic license with myth; Loki can be anything from a Puck-like trickster to a helpful fireplace deity or giant-kin.

Read this article:
One Norse God Could Be Valheim's Key to Longevity - GameRant

Posted in Longevity | Comments Off on One Norse God Could Be Valheim’s Key to Longevity – GameRant

Longevity and DeSci Recap January 2024 – Lifespan.io News

Welcome back to the latest edition of the Longevity and DeSci Recap and the first of 2024. The past year has been packed with new discoveries and releases, including Exos Iris, a hand-held AI ultrasound device; large-scale deals, such as Fauna Bio x Lilly at $494 million and ExcepGEN $14 million in seed funding; and innovations such as AthenaDAO and Zuzalu, the first pop-up city.

It seems that 2024 is shaping up to be an eventful year already. January has started with a bang with the launch of the latest pop-up city event, Vitalia, in Honduras, the news of a unique piece of technology, and an AI tool that could reinvent healthcare consultations. Here are the insights, interviews, and research in the longevity technology sphere over the past month.

Here are some of the first quarters upcoming conferences and events for all longevity enthusiasts.

The City of Life is live. Join Vitalia in Roatan, Honduras: The redefinition of the longevity landscape is already underway in Roatan, Honduras, where up to 200 residents and 500+ visitors interested in longevity are joining forces to rejuvenate the world. Inspired by the first pop-up city, Zuzalu, Vitalias schedule is packed with talks, co-working, events, and other attractions for longevity enthusiasts. Broken into four separate bi-weekly thematic areas, culminating in a summit, Vitalias participants will have a chance to explore:

Longevity and Biohacking Convention in Cancun: The Longevity and Biohacking convention in Cancun, Mexico is set to add to the fervor. For two days from March 2, 2024 to March 3, 2024, the events attendees will gather together to explore the topics of longevity and achieving peak performance, mental and physical. The schedule is packed with 34 keynotes, 60 exhibits showing the latest in longevity technology, workshops, and networking events. It will culminate with a final dinner party to round up the exciting two-day event. Tickets start from $750 and are available now.

Head back in time with the Turn Around Aging Conference: To be held in Munich in March, the Turn Around Aging Conference is dedicated to healthy longevity and solutions that can improve human health and lifespan. Supplements, lifestyle factors, and hormone replacement are set to be hot topics of discussion at the event, with ticket prices starting from 129. This conference will be held in the German language.

Over to DC for the Longevity Science Fly-In: From March 21-22, 2024, the Longevity Science Fly-In will be the host of this exclusive longevity networking-centric event. Notable names such as Newt Gingrich and experts in biotechnology will be present at the luxury Hay-Adams hotel, close to the White House. Registration for the top-level event is set at $2,000.

Rejuvenation Start-up Summit 2024 is back in Berlin: Set to be the worlds largest in-person gathering that brings together longevity start-ups, investors, and enthusiasts, this years conference will facilitate a variety of world-renowned speakers, such as Matthew Rosen of CoRegan, Alexander Leutner of cell blocks, Lifespans Stephanie Dainow, and others. This event will be held from May 10-11, 2024. Tickets are available now.

Health biotech company Timeline raises $66 million in funding: Longevity is set to take the consumer market with Timelines latest Series D funding round. The company raised a massive $66 million in an oversubscribed round led by BOLD, LOral Groupes venture capital fund to further Timelines proprietary technology, Mitopure. Mitopure, backed by 15 years of research, is claimed to enhance cellular longevity and improve mitochondrial function, a key factor in skin, strength and cognition. This latest funding will allow the company to continue its venture into the food, beauty and health sectors, bringing its longevity solution to a larger market.

New funding for early heart disease detection: CardioSignal, the tech company dedicated to improving remote cardiac care, just received $10 million in Series A funding to advance its heart disease detection technology. The smartphone-based solution aims to detect the early signs of heart disease using gyroscopic and accelerometer sensors to measure heart movements aiming to reduce deaths from cardiac disease.

Neuralink has been implanted for the first time: Much anticipated with both fear and awe, the wait is over for those speculating whether or not Elon Musks Neuralink would ever get off the ground. The start of 2024 saw the first successful implant of the proprietary technology into a human, using its unique product, Telepathy. The technology is designed to generalized brain interface to restore autonomy to those with unmet medical needs today and unlock human potential tomorrow and is aimed at those with paralysis and degenerative disease.

After much consideration, and initial safety concerns, the chip (Telepathy) was approved by the FDA for human trials and works by capturing brain signals and transmitting them via Bluetooth technology.

Can a chatbot do better medical consultations than a human?: This is the question asked by Lifespan.ios Arkadi Mazin when reviewing the latest research into a Google-made AI chatbot designed to conduct medical consultations. The technology, Articulated Medical Intelligence Explorer (AMIE) was trained using media resources and refined via iterations. It was then put to the test against primary care physicians, outperforming them in 24 out of 26 categories, including differential diagnosis, empathy and communication.

However, this study evaluates only chatting ability, which is not an area that physicians are typically trained in. Yet, this technology does present the potential to democratize healthcare and deliver a solution for resource-poor communities.

AthenaDAO announces its first Entrepreneur-in-Residence: Competition was fierce as five finalists competed to be the first-ever EIR at AthenaDAO. The final event was held as a pitch session and evaluated by three judges: Dr.Lynae Brayboy, MD, Chief Medical Officer & Co-Founder of Ovom Care; Alok Tayi, PhD, Founder and CEO of Vibe Biotechnology; and James Brodie, Chief Investment Officer at ID Theory. After a long debate, the judges selected Maria Such, PhD for the honor.

Manulife partners with UpLink in multi-year longevity initiative: The global investment management group Manulife has just announced a partnership with UpLink, the World Economic Forums open innovation platform. UpLink, launched in 2020, supports start-ups that come up with solutions for the Worlds Sustainable Development Goals and has supported over 350 entrepreneurs since its inception. The multi-year initiative led by Manulife and UpLink seeks to address the demographic and financial challenges of aging, promote longevity, and build upon the previous partnership focused on nature-based climate solutions.

Life Noggin YouTube: If you havent already subscribed, nows the time to learn more about longevity and other topics in quick, easy-to-understand videos.

Lifespan.io News: Hosted by Emmett Short, Lifespan.io News covers the latest in longevity in video form.

Christian Angermayers Instagram: Christian Angermayer is an entrepreneur, biotech founder and longevity enthusiast. Follow to hear the latest insights and investment news.

To do this, we need your support. Your charitable contribution tranforms into rejuvenation research, news, shows, and more. Will you help?

Here is the original post:
Longevity and DeSci Recap January 2024 - Lifespan.io News

Posted in Longevity | Comments Off on Longevity and DeSci Recap January 2024 – Lifespan.io News